AAAAAA

   
Results: 1-16 |
Results: 16
PROGNOSTIC-SIGNIFICANCE OF COMBINED DETECTION OF TYROSINASE AND GAUGEMESSENGER-RNAS IN THE PERIPHERAL-BLOOD (PB) AND BONE-MARROW (BM) OF PATIENTS WITH MALIGNANT-MELANOMA (MM)
Authors: GHOSSEIN R CHEUNG I CHEUNG NK VENKATRAMAN E COIT D ROSAI J
Citation: R. Ghossein et al., PROGNOSTIC-SIGNIFICANCE OF COMBINED DETECTION OF TYROSINASE AND GAUGEMESSENGER-RNAS IN THE PERIPHERAL-BLOOD (PB) AND BONE-MARROW (BM) OF PATIENTS WITH MALIGNANT-MELANOMA (MM), Modern pathology, 11(1), 1998, pp. 49-49
PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER
Authors: AGHAJANIAN C FENNELLY D SHAPIRO F WALTZMAN R ALMADRONES L OFLAHERTY C OCONNER K VENKATRAMAN E BARAKAT R CURTIN J BROWN C REICH L WUEST D NORTON L HOSKINS W SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1852-1860
PROPOSED REVISION OF THE STAGING CLASSIFICATION FOR ESOPHAGEAL CANCER
Authors: KORST RJ RUSCH VW VENKATRAMAN E BAINS MS BURT ME DOWNEY RJ GINSBERG RJ
Citation: Rj. Korst et al., PROPOSED REVISION OF THE STAGING CLASSIFICATION FOR ESOPHAGEAL CANCER, Journal of thoracic and cardiovascular surgery, 115(3), 1998, pp. 660-669
HIGH TELOMERASE ACTIVITY IN PRIMARY LUNG CANCERS - ASSOCIATION WITH INCREASED CELL-PROLIFERATION RATES AND ADVANCED PATHOLOGICAL STAGE
Authors: ALBANELL J LONARDO F RUSCH V ENGELHARDT M LANGENFELD J HAN W KLIMSTRA D VENKATRAMAN E MOORE MAS DMITROVSKY E
Citation: J. Albanell et al., HIGH TELOMERASE ACTIVITY IN PRIMARY LUNG CANCERS - ASSOCIATION WITH INCREASED CELL-PROLIFERATION RATES AND ADVANCED PATHOLOGICAL STAGE, Journal of the National Cancer Institute, 89(21), 1997, pp. 1609-1615
DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY MX35 F(AB')2 IN TISSUE SAMPLES BY STORAGE PHOSPHOR SCREEN IMAGE-ANALYSIS - EVALUATION OF ANTIBODY LOCALIZATION TO MICROMETASTATIC DISEASE IN EPITHELIAL OVARIAN-CANCER
Authors: FINSTAD CL LLOYD KO FEDERICI MG DIVGI C VENKATRAMAN E BARAKAT RR FINN RD LARSON SM HOSKINS WJ HUMM JL
Citation: Cl. Finstad et al., DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY MX35 F(AB')2 IN TISSUE SAMPLES BY STORAGE PHOSPHOR SCREEN IMAGE-ANALYSIS - EVALUATION OF ANTIBODY LOCALIZATION TO MICROMETASTATIC DISEASE IN EPITHELIAL OVARIAN-CANCER, Clinical cancer research, 3(8), 1997, pp. 1433-1442
OVEREXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ITS LIGANDTRANSFORMING-GROWTH-FACTOR-ALPHA IS FREQUENT IN RESECTABLE NONSMALL CELL LUNG-CANCER BUT DOES NOT PREDICT TUMOR PROGRESSION
Authors: RUSCH V KLIMSTRA D VENKATRAMAN E PISTERS PWT LANGENFELD J DMITROVSKY E
Citation: V. Rusch et al., OVEREXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ITS LIGANDTRANSFORMING-GROWTH-FACTOR-ALPHA IS FREQUENT IN RESECTABLE NONSMALL CELL LUNG-CANCER BUT DOES NOT PREDICT TUMOR PROGRESSION, Clinical cancer research, 3(4), 1997, pp. 515-522
HIGH-INTENSITY INTRAVENOUS CYCLOPHOSPHAMIDE AND CISPLATIN, INTERIM SURGICAL DEBULKING, AND INTRAPERITONEAL CISPLATIN IN ADVANCED OVARIAN-CARCINOMA - A PILOT TRIAL WITH 10-YEAR FOLLOW-UP
Authors: SHAPIRO F SCHNEIDER J MARKMAN M REICHMAN BS VENKATRAMAN E BARAKAT R ALMADRONES L SPRIGGS D
Citation: F. Shapiro et al., HIGH-INTENSITY INTRAVENOUS CYCLOPHOSPHAMIDE AND CISPLATIN, INTERIM SURGICAL DEBULKING, AND INTRAPERITONEAL CISPLATIN IN ADVANCED OVARIAN-CARCINOMA - A PILOT TRIAL WITH 10-YEAR FOLLOW-UP, Gynecologic oncology, 67(1), 1997, pp. 39-45
CHEMOTHERAPY AND TOTAL PARENTERAL-NUTRITION FOR ADVANCED OVARIAN-CANCER WITH BOWEL OBSTRUCTION
Authors: ABURUSTUM NR BARAKAT RR VENKATRAMAN E SPRIGGS D
Citation: Nr. Aburustum et al., CHEMOTHERAPY AND TOTAL PARENTERAL-NUTRITION FOR ADVANCED OVARIAN-CANCER WITH BOWEL OBSTRUCTION, Gynecologic oncology, 64(3), 1997, pp. 493-495
INTRACRANIAL ABSCESSES AT MEMORIAL-SLOAN-KETTERING-CANCER-CENTER (MSKCC) 1980-1996
Authors: HARIHARAN S THIESSEN B VENKATRAMAN E MALKIN MG
Citation: S. Hariharan et al., INTRACRANIAL ABSCESSES AT MEMORIAL-SLOAN-KETTERING-CANCER-CENTER (MSKCC) 1980-1996, Neurology, 48(3), 1997, pp. 4014-4014
EXPRESSION OF A-BLOOD-GROUP, B-BLOOD-GROUP, AND H-BLOOD-GROUP ANTIGENS IN EPITHELIAL OVARIAN-CANCER - RELATIONSHIP TO TUMOR GRADE AND PATIENT SURVIVAL
Authors: WELSHINGER M FINSTAD CL VENKATRAMAN E FEDERICI MG RUBIN SC LEWIS JL LLOYD KO
Citation: M. Welshinger et al., EXPRESSION OF A-BLOOD-GROUP, B-BLOOD-GROUP, AND H-BLOOD-GROUP ANTIGENS IN EPITHELIAL OVARIAN-CANCER - RELATIONSHIP TO TUMOR GRADE AND PATIENT SURVIVAL, Gynecologic oncology, 62(1), 1996, pp. 106-112
2ND-LOOK OPERATION FOR EPITHELIAL OVARIAN-CANCER - LAPAROSCOPY OR LAPAROTOMY
Authors: ABURUSTUM NR BARAKAT RR SIEGEL PL VENKATRAMAN E CURTIN JP HOSKINS WJ
Citation: Nr. Aburustum et al., 2ND-LOOK OPERATION FOR EPITHELIAL OVARIAN-CANCER - LAPAROSCOPY OR LAPAROTOMY, Obstetrics and gynecology, 88(4), 1996, pp. 549-553
THE IMPORTANCE OF SURGICAL STAGING IN THE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA
Authors: RUSCH VW VENKATRAMAN E
Citation: Vw. Rusch et E. Venkatraman, THE IMPORTANCE OF SURGICAL STAGING IN THE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA, Journal of thoracic and cardiovascular surgery, 111(4), 1996, pp. 815-826
ARE MORE ANTIEMETIC TRIALS WITH A PLACEBO NECESSARY - REPORT OF PATIENT DATA FROM RANDOMIZED TRIALS OF PLACEBO ANTIEMETICS WITH CISPLATIN
Authors: KRIS MG CUBEDDU LX GRALLA RJ CUPISSOL D TYSON LB VENKATRAMAN E HOMESLEY HD
Citation: Mg. Kris et al., ARE MORE ANTIEMETIC TRIALS WITH A PLACEBO NECESSARY - REPORT OF PATIENT DATA FROM RANDOMIZED TRIALS OF PLACEBO ANTIEMETICS WITH CISPLATIN, Cancer, 78(10), 1996, pp. 2193-2198
ABERRANT P53 EXPRESSION PREDICTS CLINICAL RESISTANCE TO CISPLATIN-BASED CHEMOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: RUSCH V KLIMSTRA D VENKATRAMAN E OLIVER J MARTINI N GRALLA R KRIS M DMITROVSKY E
Citation: V. Rusch et al., ABERRANT P53 EXPRESSION PREDICTS CLINICAL RESISTANCE TO CISPLATIN-BASED CHEMOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER, Cancer research, 55(21), 1995, pp. 5038-5042
A PHASE-II TRIAL OF PLEURECTOMY DECORTICATION FOLLOWED BY INTRAPLEURAL AND SYSTEMIC CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA/
Authors: RUSCH V SALTZ L VENKATRAMAN E GINSBERG R MCCORMACK P BURT M MARKMAN M KELSEN D
Citation: V. Rusch et al., A PHASE-II TRIAL OF PLEURECTOMY DECORTICATION FOLLOWED BY INTRAPLEURAL AND SYSTEMIC CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA/, Journal of clinical oncology, 12(6), 1994, pp. 1156-1163
MODULATION OF ALL-TRANS-RETINOIC ACID PHARMACOKINETICS BY LIAROZOLE
Authors: MILLER VA RIGAS JR MUINDI JRF TONG WP VENKATRAMAN E KRIS MG WARRELL RP
Citation: Va. Miller et al., MODULATION OF ALL-TRANS-RETINOIC ACID PHARMACOKINETICS BY LIAROZOLE, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 522-526
Risultati: 1-16 |